An FDA expert panel on Thursday unanimously recommended that the U.S. overhaul its pandemic vaccine strategy and replace initial doses of original COVID shots with bivalent ones that target specific Omicron subvariants.
, leading at time to public confusion. With all available vaccines following one single composition, health experts argued that vaccination rates could increase.and modify shots as new variants emerge.
FDA officials and committee members said during the meeting of the Vaccines and Related Biological Products Advisory Committee, or VRBPAC, that there was a need to simplify vaccine composition, adding that the current differences make it harder for people to decide whether to get vaccinated.
While Pfizer and Moderna suggested that bivalent vaccines were more protective, Novavax argued that bivalent and monovalent shots "perform comparably."The choice to have all circulating vaccines be bivalent might be particularly challenging to Novavax, considering the company has not yet produced a bivalent shot.Gellin at one point asked Pfizer during its presentation whether it believed that a U.S. vaccine strategy would dictate what shots become available worldwide.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
FDA vaccine panel to consider recommending annual COVID shots: What we knowThe Food and Drug Administration on Thursday is asking an expert advisory panel to consider how often people should be boosted against COVID-19 and what those boosters should look like.
Read more »
FDA panel to consider simpler COVID vaccine processThe agency is proposing that a single COVID shot be approved each year for most people, one targeting a specific strain or strains of concern at the time of approval. A panel of independent advisers is set to consider and vote on the proposal Thursday.
Read more »
FDA vaccine panel to consider annual COVID shots: What we knowThe FDA on Thursday is asking an expert advisory panel to consider how often people should be boosted against COVID-19 and what those boosters should look like.
Read more »
A panel of experts answer questions about the COVID-19 booster shot during an FDA meetingHow often should Americans get their booster shot against COVID-19, and how important is the booster to you if you’ve already been infected with COVID-19? Those are questions a panel of experts set out to answer during an FDA meeting, the information will be passed on to the CDC.
Read more »
The FDA Considers New Plan of Administering COVID-19 VaccinesThe Food and Drug Administration is considering a shift to a new way of administering the COVID-19 vaccine that is akin to receiving the flu shot. The FDA’s vaccine advisory committee will meet Thursday to discuss this proposed change, as well as other updates concerning the status of current and...
Read more »
FDA Wants Annual COVID Vaccinations Just Like Annual Flu Shots– U.S. health officials want to simplify the recommended COVID-19 vaccine protocol, making it more like the process for annual flu shots with a single annual shot.
Read more »